Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 4.53%84.81B | 5.82%341.44B | 0.56%86.87B | 11.74%81.14B | 0.98%322.65B | 80.83B | 9.30%86.39B | -4.01%82.82B | -11.17%72.61B | -8.62%319.5B |
| Cost of revenue | 4.67%66.63B | 4.93%269.87B | 5.12%70.53B | 6.35%63.66B | 10.82%257.19B | 64.62B | 15.38%67.09B | 18.16%65.63B | 9.39%59.85B | 3.31%232.09B |
| Gross profit | 4.02%18.18B | 9.34%71.57B | -15.31%16.34B | 37.02%17.48B | -25.12%65.46B | 16.22B | -7.61%19.3B | -44.08%17.18B | -52.78%12.76B | -30.05%87.42B |
| Operating expense | 1.29%15.04B | 8.40%61.11B | 7.79%15.52B | 11.35%14.85B | 1.69%56.38B | 14.18B | -0.21%14.4B | 1.45%14.46B | -3.91%13.34B | -2.33%55.44B |
| Operating profit | 19.42%3.14B | 15.20%10.46B | -83.17%825M | 555.19%2.63B | -71.61%9.08B | 2.04B | -24.14%4.9B | -83.49%2.72B | -104.40%-578M | -53.12%31.98B |
| Net non-operating interest income (expenses) | -87.87%33M | 29.41%660M | 266.67%143M | 75.48%272M | 96.15%510M | 195M | -64.86%39M | 89.06%121M | 600.00%155M | 326.09%260M |
| Non-operating interest income | -32.58%298M | 17.15%1.55B | 11.53%387M | 51.89%442M | 83.13%1.32B | --377M | 52.86%347M | 71.67%309M | 304.17%291M | 162.91%723M |
| Non-operating interest expense | 55.88%265M | 27.65%891M | 27.08%244M | 25.00%170M | 50.76%698M | --182M | 65.52%192M | 62.07%188M | 32.04%136M | 18.72%463M |
| Total other finance cost | ---- | ---- | ---- | ---- | --116M | --0 | ---- | ---- | ---- | ---- |
| Net investment income | -155.48%-2.98B | -120.38%-819M | 250.01%5.96B | 187.33%5.37B | 235.67%4.02B | 3.93B | 8.06%-3.97B | 38.80%2.19B | -52.85%1.87B | -63.93%1.2B |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 184.75%504M | -4M | -92.68%12M | 177M | 13M | 0 | 0 | 164M | 0 |
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -1.49%-272M | -195.40%-2.95B | -93.00%-193M | -194.51%-268M | 73.58%-999M | -630M | -1,528.57%-100M | 53.65%-178M | 55.61%-91M | -322.46%-3.78B |
| Less:Restructuring and mergern&acquisition | --432M | --324M | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- |
| Less:Other special charges | -222.06%-249M | 168.76%2.31B | 75.76%116M | 183.33%204M | -76.79%861M | --576M | 414.29%66M | -60.59%147M | -63.82%72M | 484.09%3.71B |
| Less:Write off | 39.06%89M | 126.81%313M | 126.47%77M | 236.84%64M | 91.67%138M | --54M | 142.86%34M | 181.82%31M | 216.67%19M | -72.31%72M |
| Other non-operating income (expenses) | -7.83%153M | 79.79%516M | -67.51%77M | 161.71%166M | -80.15%287M | 196M | -28.40%237M | -49.38%123M | -303.79%-269M | 70.32%1.45B |
| Income before tax | -99.11%73M | -36.01%8.37B | 516.95%6.81B | 554.28%8.19B | -57.97%13.07B | 5.74B | -57.48%1.1B | -72.30%4.98B | -92.64%1.25B | -56.73%31.1B |
| Income tax | -49.41%949M | 26.96%6.04B | 167.07%2.21B | 439.08%1.88B | -39.70%4.76B | 1.1B | 33.01%826M | -53.46%2.48B | -92.70%348M | -54.96%7.89B |
| Net income | -113.88%-876M | -72.01%2.33B | 1,566.30%4.6B | 598.67%6.31B | -64.18%8.32B | 4.64B | -86.01%276M | -80.25%2.5B | -92.62%903M | -57.29%23.22B |
| Net income continuous operations | -113.88%-876M | -72.01%2.33B | 1,560.29%4.6B | 598.67%6.31B | -64.17%8.32B | --4.64B | -85.96%277M | -80.25%2.5B | -92.62%903M | -57.29%23.22B |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -113.88%-876M | -72.01%2.33B | 1,566.30%4.6B | 598.67%6.31B | -64.18%8.32B | 4.64B | -86.01%276M | -80.25%2.5B | -92.62%903M | -57.29%23.22B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -113.88%-876M | -72.01%2.33B | 1,566.30%4.6B | 598.67%6.31B | -64.18%8.32B | 4.64B | -86.01%276M | -80.25%2.5B | -92.62%903M | -57.29%23.22B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -113.87%-7.02 | -72.03%18.67 | 1,568.78%36.88 | 598.21%50.62 | -64.17%66.75 | 37.25 | -86.04%2.21 | -80.25%20.04 | -92.62%7.25 | -57.02%186.32 |
| Diluted earnings per share | -115.26%-7.02 | -74.59%16.13 | 2,413.53%33.43 | 536.98%45.99 | -65.81%63.49 | 34.96 | -91.57%1.33 | -80.24%19.98 | -92.63%7.22 | -57.03%185.71 |
| Dividend per share | 0 | 0.00%90 | 0 | 0 | 0.00%90 | 45 | 0 | 0.00%45 | 0 | 12.50%90 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |